Cargando…

Comparing and evaluating the efficacy of methotrexate and actinomycin D as first-line single chemotherapy agents in low risk gestational trophoblastic disease

OBJECTIVE: The aim of this study was to compare responses to single-agent chemotherapies and evaluate the predictive factors of resistance in low risk (LR) gestational trophoblastic disease (GTD). The chemotherapy agents included methotrexate (MTX) and actinomycin D (ACT-D). METHODS: We conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Young-Jae, Park, Jeong-Yeol, Kim, Dae-Yeon, Suh, Dae-Shik, Kim, Jong-Hyeok, Kim, Yong-Man, Kim, Young-Tak, Nam, Joo-Hyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323289/ https://www.ncbi.nlm.nih.gov/pubmed/27819410 http://dx.doi.org/10.3802/jgo.2017.28.e8

Ejemplares similares

Hexamethylmelamine as Consolidation Treatment for Patients with Advanced Epithelial Ovarian Cancer in Complete Response after First-Line Chemotherapy
por: Kwon, Yong Soon, et al.
Publicado: (2009)

Reproductive outcomes after laparoscopic radical trachelectomy for early-stage cervical cancer
por: Park, Jeong-Yeol, et al.
Publicado: (2014)

Clinical Role of Adjuvant Chemotherapy after Radical Hysterectomy for FIGO Stage IB-IIA Cervical Cancer: Comparison with Adjuvant RT/CCRT Using Inverse-Probability-of-Treatment Weighting
por: Jung, Phill-Seung, et al.
Publicado: (2015)

Trends in treatment during the last stages of life in end-stage gynecologic cancer patients who received active palliative chemotherapy: a comparative analysis of 10-year data in a single institution
por: Jang, Tae-Kyu, et al.
Publicado: (2018)

Outcome of treatment with EMA/EP (etoposide methotrexate and actinomycin-D/ etoposide and cisplatin) regimen in gestational trophoblastic neoplasia
por: Aminimoghaddam, Soheila, et al.
Publicado: (2018)

Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience
por: Lee, Young-Jae, et al.
Publicado: (2017)

The efficacy and safety of pegylated liposomal doxorubicin monotherapy and combination therapy with carboplatin in Korean patients with recurrent ovarian, fallopian tube, or primary peritoneal cancer: a single-institution experience
por: Lee, Young-Jae, et al.
Publicado: (2017)

Comparison of the efficacy of methotrexate and actinomycin D in the treatment of patients with stage I low risk gestational trophoblastic neoplasia (GTN)
por: Shahbazian, Nahid, et al.
Publicado: (2014)

The efficacy of sentinel lymph node mapping with indocyanine green in cervical cancer
por: Kim, Ju-Hyun, et al.
Publicado: (2018)

Outcomes and prognostic factors of surgically treated extramammary Paget’s disease of the vulva
por: Cho, Angela, et al.
Publicado: (2023)

Feasibility and safety of fertility-sparing surgery in epithelial ovarian cancer with dense adhesion: a long-term result from a single institution
por: Baek, Min-Hyun, et al.
Publicado: (2020)

Laparoendoscopic single-site versus conventional laparoscopic surgery for ovarian mature cystic teratoma
por: Park, Jeong-Yeol, et al.
Publicado: (2015)

Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma
por: Baek, Min-Hyun, et al.
Publicado: (2018)

Stratification of risk groups according to survival after recurrence in endometrial cancer patients
por: Shim, Seung-Hyuk, et al.
Publicado: (2017)

Effect of actinomycin D on ovarian reserve in low-risk gestational trophoblastic neoplasia
por: Xue, Wei, et al.
Publicado: (2023)

Hepatic toxicity following actinomycin D chemotherapy in treatment of familial gestational trophoblastic neoplasia: A case report
por: Mu, Xiyan, et al.
Publicado: (2018)

Erratum: Author correction
por: Lee, Young-Jae, et al.
Publicado: (2017)

Increasing the human chorionic gonadotrophin cut-off to ≤1000 IU/l for starting actinomycin D in post-molar gestational trophoblastic neoplasia developing resistance to methotrexate spares more women multi-agent chemotherapy
por: Cortés-Charry, R., et al.
Publicado: (2021)

Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm
por: Peng, Mei, et al.
Publicado: (2015)

Actinomycin D shortage in the Brazilian market: new challenges for successful treatment of gestational trophoblastic neoplasia
por: Paulino, Eduardo, et al.
Publicado: (2019)

Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report
por: Mikami, Yukiko, et al.
Publicado: (2016)

Pulse actinomycin D as first-line treatment of low-risk post-molar non-choriocarcinoma gestational trophoblastic neoplasia
por: Li, Lei, et al.
Publicado: (2018)

An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275
por: Schink, Julian C., et al.
Publicado: (2020)

Impact of body mass index on the prognosis of Korean women with endometrioid adenocarcinoma of the uterus: A cohort study
por: Park, Jeong-Yeol, et al.
Publicado: (2014)

Role of surgical therapy in the management of gestational trophoblastic neoplasia
por: Eoh, Kyung Jin, et al.
Publicado: (2015)

Methotrexate pneumonitis in a patient with gestational trophoblastic neoplasia
por: Agarwal, M, et al.
Publicado: (2022)

Concomitant ultrasound-guided intra-gestational sac methotrexate-potassium chloride and systemic methotrexate injection in the recurrent cesarean scar pregnancy
por: Lee, Ju Hak, et al.
Publicado: (2016)

Single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Mousavi Seresht, Leila, et al.
Publicado: (2023)

Direct comparisons of efficacy and safety between actinomycin-D and methotrexate in women with low-risk gestational trophoblastic neoplasia: a meta-analysis of randomized and high-quality non-randomized studies
por: Hao, Jiatao, et al.
Publicado: (2021)

Single-Incision versus Multiport Robotic Myomectomy: A Propensity Score Matched Analysis of Surgical Outcomes and Surgical Tips
por: Lee, Sa-Ra, et al.
Publicado: (2021)

Robot-Assisted Laparoscopic Myomectomy versus Abdominal Myomectomy for Large Myomas Sized over 10 cm or Weighing 250 g
por: Lee, Sa Ra, et al.
Publicado: (2020)

Resistance to single-agent chemotherapy in low-risk gestational trophoblastic neoplasia
por: Sheikhhasani, Shahrzad, et al.
Publicado: (2023)

Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis
por: Sharma, S, et al.
Publicado: (1999)

Mutational Analysis of KRAS, BRAF, and TP53 Genes of Ovarian Serous Carcinomas in Korean Women
por: Cho, Yun-Hyun, et al.
Publicado: (2009)

Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy
por: Tu, Xiaoyu, et al.
Publicado: (2020)

Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer
por: Song, Changho, et al.
Publicado: (2023)

Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0–4): study protocol for a prospective, multicentre, randomized trial
por: Jiang, Fang, et al.
Publicado: (2023)

The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy
por: Wu, Xiaodong, et al.
Publicado: (2020)

New Surgical Technique for Robotic Myomectomy: Continuous Locking Suture on Myoma (LSOM) Technique
por: Lee, Sa Ra, et al.
Publicado: (2021)

In vitro and in silico evaluations of actinomycin X(2)and actinomycin D as potent anti-tuberculosis agents
por: Qureshi, Kamal Ahmad, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ie2010cs9m9p6tqklbetdusntb